Te‐Hsin Lung

490 total citations
18 papers, 261 citations indexed

About

Te‐Hsin Lung is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Epidemiology. According to data from OpenAlex, Te‐Hsin Lung has authored 18 papers receiving a total of 261 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 5 papers in Surgery and 5 papers in Epidemiology. Recurrent topics in Te‐Hsin Lung's work include Cardiac Valve Diseases and Treatments (6 papers), Coronary Interventions and Diagnostics (4 papers) and Congenital Heart Disease Studies (4 papers). Te‐Hsin Lung is often cited by papers focused on Cardiac Valve Diseases and Treatments (6 papers), Coronary Interventions and Diagnostics (4 papers) and Congenital Heart Disease Studies (4 papers). Te‐Hsin Lung collaborates with scholars based in United States, Ireland and Switzerland. Te‐Hsin Lung's co-authors include Lisa Bergersen, John P. Cheatham, Matthew J. Gillespie, Doff B. McElhinney, Thomas K. Jones, Lee Benson, David T. Balzer, Mark Osten, Andreas Eicken and Felix Berger and has published in prestigious journals such as Journal of the American College of Cardiology, Hypertension and The American Journal of Cardiology.

In The Last Decade

Te‐Hsin Lung

17 papers receiving 259 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Te‐Hsin Lung United States 6 221 209 102 78 18 18 261
Lorenz Hansen Germany 10 382 1.7× 280 1.3× 132 1.3× 123 1.6× 21 1.2× 17 403
Francesca Chiaramonti Italy 9 309 1.4× 208 1.0× 141 1.4× 147 1.9× 21 1.2× 21 336
Bobby Kong United States 6 258 1.2× 177 0.8× 129 1.3× 144 1.8× 22 1.2× 6 316
Magali Michel France 4 149 0.7× 139 0.7× 83 0.8× 68 0.9× 32 1.8× 6 183
Amee Shah United States 8 168 0.8× 162 0.8× 85 0.8× 88 1.1× 26 1.4× 35 258
Nagaki Kiyohara Japan 5 246 1.1× 243 1.2× 235 2.3× 71 0.9× 21 1.2× 6 307
Sharaf-Eldin Shehada Germany 10 252 1.1× 140 0.7× 155 1.5× 177 2.3× 19 1.1× 37 328
Stanimir Georgiev Germany 10 141 0.6× 231 1.1× 145 1.4× 104 1.3× 29 1.6× 60 272
Roman Pachulski United States 7 258 1.2× 120 0.6× 166 1.6× 74 0.9× 13 0.7× 15 315
G J F Hoohenkerk Netherlands 7 141 0.6× 182 0.9× 80 0.8× 120 1.5× 9 0.5× 14 211

Countries citing papers authored by Te‐Hsin Lung

Since Specialization
Citations

This map shows the geographic impact of Te‐Hsin Lung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Te‐Hsin Lung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Te‐Hsin Lung more than expected).

Fields of papers citing papers by Te‐Hsin Lung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Te‐Hsin Lung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Te‐Hsin Lung. The network helps show where Te‐Hsin Lung may publish in the future.

Co-authorship network of co-authors of Te‐Hsin Lung

This figure shows the co-authorship network connecting the top 25 collaborators of Te‐Hsin Lung. A scholar is included among the top collaborators of Te‐Hsin Lung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Te‐Hsin Lung. Te‐Hsin Lung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Mahfoud, Felix, David E. Kandzari, Markus P. Schlaich, et al.. (2025). Long-term outcomes following radiofrequency renal denervation: meta-analysis of 18 reports. European Journal of Preventive Cardiology. 1 indexed citations
2.
Schlaich, Markus P., Felix Mahfoud, Michael Böhm, et al.. (2025). Renal Denervation in Patients With Moderate to Severe Chronic Kidney Disease. Hypertension. 82(12). 2252–2261.
3.
Price, Matthew J., Ajay J. Kirtane, Stanley Chetcuti, et al.. (2023). Three-Year Outcomes After Bifurcation Stenting With Zotarolimus-Eluting Stents: Final Results From the RESOLUTE ONYX Postapproval Study. Journal of the Society for Cardiovascular Angiography & Interventions. 2(6). 101116–101116. 1 indexed citations
4.
Tóth, Gábor G., David E. Kandzari, Ajay J. Kirtane, et al.. (2023). Two-year results from Onyx ONE clear in patients with high bleeding risk on one-month DAPT with and without intracoronary imaging. Cardiovascular revascularization medicine. 58. 60–67. 1 indexed citations
5.
Kandzari, David E., Azeem Latib, Elvin Kedhi, et al.. (2022). TCT-2 Two-Year Outcomes in High Bleeding Risk Patients With Bifurcations After Percutaneous Coronary Intervention and One Month of Dual Antiplatelet Therapy. Journal of the American College of Cardiology. 80(12). B1–B1. 1 indexed citations
6.
Price, Matthew J., Ajay J. Kirtane, Stanley Chetcuti, et al.. (2022). B-25 | Two-Year Outcomes in Patients with Bifurcation Lesions treated with Resolute ONYX ZES: Final Results from the RESOLUTE ONYX Bifurcation Study. Journal of the Society for Cardiovascular Angiography & Interventions. 1(3). 100132–100132. 2 indexed citations
7.
Windecker, Stephan, Elvin Kedhi, Azeem Latib, et al.. (2021). FINAL TWO-YEAR RESULTS FROM THE RANDOMIZED ONYX ONE TRIAL IN HIGH BLEEDING RISK PATIENTS TREATED WITH 1-MONTH DAPT. Journal of the American College of Cardiology. 77(18). 899–899. 2 indexed citations
8.
Kirtane, Ajay J., Stanley Chetcuti, Petra Poliačiková, et al.. (2021). ONE YEAR CLINICAL OUTCOMES IN PATIENTS WITH CORONARY BIFURCATION LESIONS: RESULTS FROM THE RESOLUTE ONYX BIFURCATION STUDY. Journal of the American College of Cardiology. 77(18). 965–965. 1 indexed citations
9.
Kirtane, Ajay J., David E. Kandzari, Roxana Mehran, et al.. (2020). ONE MONTH DUAL ANTIPLATELET THERAPY IN HIGH BLEEDING RISK PATIENTS: PRIMARY RESULTS FROM THE ONYX ONE CLEAR STUDY. Journal of the American College of Cardiology. 75(11). 1097–1097. 2 indexed citations
10.
Armstrong, Aimee K., Felix Berger, Thomas K. Jones, et al.. (2019). Association between patient age at implant and outcomes after transcatheter pulmonary valve replacement in the multicenter Melody valve trials. Catheterization and Cardiovascular Interventions. 94(4). 607–617. 20 indexed citations
11.
McElhinney, Doff B., Lars Søndergaard, Aimee K. Armstrong, et al.. (2018). Endocarditis After Transcatheter Pulmonary Valve Replacement. Journal of the American College of Cardiology. 72(22). 2717–2728. 76 indexed citations
12.
Morray, Brian H., Thomas K. Jones, James Y. Coe, et al.. (2018). Implantation of the Melody transcatheter pulmonary valve PB1016 in patients with dysfunctional right ventricular outflow tract conduits. Catheterization and Cardiovascular Interventions. 93(3). 474–480. 3 indexed citations
13.
Bergersen, Lisa, Lee Benson, Matthew J. Gillespie, et al.. (2017). Harmony Feasibility Trial. JACC: Cardiovascular Interventions. 10(17). 1763–1773. 88 indexed citations
14.
Cabalka, Allison K., Jeremy D. Asnes, David T. Balzer, et al.. (2017). Transcatheter pulmonary valve replacement using the melody valve for treatment of dysfunctional surgical bioprostheses: A multicenter study. Journal of Thoracic and Cardiovascular Surgery. 155(4). 1712–1724.e1. 39 indexed citations
15.
Whellan, David J., Christopher M. O’Connor, Kevin T. Ousdigian, & Te‐Hsin Lung. (2008). Rationale, design, and baseline characteristics of a Program to Assess and Review Trending INformation and Evaluate CorRelation to Symptoms in Patients with Heart Failure (PARTNERS HF). American Heart Journal. 156(5). 833–839.e2. 11 indexed citations
16.
17.
Pérez, Francisco Javier Moreno, Te‐Hsin Lung, Kenneth A. Ellenbogen, & Mark A. Wood. (2006). Is Time to First Recurrence of Atrial Fibrillation Correlated With Atrial Fibrillation Burden?. The American Journal of Cardiology. 97(9). 1343–1345. 9 indexed citations
18.
Pérez, Francisco Javier Moreno, Te‐Hsin Lung, Kenneth A. Ellenbogen, & Mark A. Wood. (2005). Is time to first recurrence of atrial fibrillation correlated with atrial fibrillation burden?. Heart Rhythm. 2(5). S310–S310. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lorenz Hansen Breakdown of academic impact, for papers by Francesca Chiaramonti Breakdown of academic impact, for papers by Bobby Kong Breakdown of academic impact, for papers by Magali Michel Breakdown of academic impact, for papers by Amee Shah Breakdown of academic impact, for papers by Nagaki Kiyohara Breakdown of academic impact, for papers by Sharaf-Eldin Shehada Breakdown of academic impact, for papers by Stanimir Georgiev Breakdown of academic impact, for papers by Roman Pachulski Breakdown of academic impact, for papers by G J F Hoohenkerk
Rankless by CCL
2026